Effects of HIV and Hepatitis C Virus on the Brain
NCT00494936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2015-05-25
Summary
This study will determine the effects that HIV and hepatitis C virus have on thinking abilities and whether the viruses affect brain chemistry.
Conditions
- HIV Infections
- Hepatitis C
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Elizabeth Ryan, PhD · Icahn School of Medicine at Mount Sinai
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- United States
Study Locations
More Related Trials
-
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
NCT00136214 ·Status: COMPLETED
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED
-
Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults
NCT01472354 ·Status: COMPLETED ·Phase: NA
-
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
NCT00655226 ·Status: TERMINATED ·Phase: NA
-
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
NCT00788918 ·Status: COMPLETED ·Phase: NA
-
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732 ·Status: COMPLETED ·Phase: NA
-
Psychobiological Characterization of Depression in Hepatitis C
NCT01492478 ·Status: UNKNOWN
-
Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)
NCT02745132 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031 ·Status: COMPLETED ·Phase: PHASE4
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
Examining Hepatitis C Reinfection Rates in Kenya
NCT03564639 ·Status: COMPLETED
-
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
NCT03894696 ·Status: UNKNOWN
-
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China
NCT01647191 ·Status: COMPLETED ·Phase: NA
-
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
NCT00218556 ·Status: COMPLETED ·Phase: NA
-
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
NCT03364725 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Prevalence of Hepatitis C In a psychiatRic Population
NCT04600479 ·Status: COMPLETED ·Phase: NA
-
P300 in Early Cognitive Impairment in Hepatitis C Virus
NCT04389268 ·Status: COMPLETED
-
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
NCT01813266 ·Status: WITHDRAWN
-
The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability
NCT01265693 ·Status: COMPLETED
-
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
NCT03268317 ·Status: UNKNOWN
-
Anticipated and Perceived Benefits Following Hepatitis C Treatment
NCT03000023 ·Status: COMPLETED
-
Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy
NCT02469012 ·Status: UNKNOWN ·Phase: NA
-
Hepatitis C Treatment and Atherosclerosis
NCT00659256 ·Status: COMPLETED
-
Hepatitis C Infection in World Trade Center Responders
NCT02982993 ·Status: COMPLETED